nodes	percent_of_prediction	percent_of_DWPC	metapath
Ertapenem—Rash—Cisplatin—hematologic cancer	5.7e-05	5.7e-05	CcSEcCtD
Ertapenem—Dermatitis—Cisplatin—hematologic cancer	5.7e-05	5.7e-05	CcSEcCtD
Ertapenem—Malnutrition—Epirubicin—hematologic cancer	5.69e-05	5.69e-05	CcSEcCtD
Ertapenem—Erythema—Epirubicin—hematologic cancer	5.69e-05	5.69e-05	CcSEcCtD
Ertapenem—Diarrhoea—Etoposide—hematologic cancer	5.67e-05	5.67e-05	CcSEcCtD
Ertapenem—Anorexia—Prednisone—hematologic cancer	5.66e-05	5.66e-05	CcSEcCtD
Ertapenem—Eye disorder—Doxorubicin—hematologic cancer	5.65e-05	5.65e-05	CcSEcCtD
Ertapenem—Ill-defined disorder—Methotrexate—hematologic cancer	5.64e-05	5.64e-05	CcSEcCtD
Ertapenem—Anaemia—Methotrexate—hematologic cancer	5.62e-05	5.62e-05	CcSEcCtD
Ertapenem—Feeling abnormal—Betamethasone—hematologic cancer	5.62e-05	5.62e-05	CcSEcCtD
Ertapenem—Feeling abnormal—Dexamethasone—hematologic cancer	5.62e-05	5.62e-05	CcSEcCtD
Ertapenem—Cardiac disorder—Doxorubicin—hematologic cancer	5.61e-05	5.61e-05	CcSEcCtD
Ertapenem—Flushing—Doxorubicin—hematologic cancer	5.61e-05	5.61e-05	CcSEcCtD
Ertapenem—Flatulence—Epirubicin—hematologic cancer	5.61e-05	5.61e-05	CcSEcCtD
Ertapenem—Tension—Epirubicin—hematologic cancer	5.58e-05	5.58e-05	CcSEcCtD
Ertapenem—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.57e-05	5.57e-05	CcSEcCtD
Ertapenem—Gastrointestinal pain—Betamethasone—hematologic cancer	5.57e-05	5.57e-05	CcSEcCtD
Ertapenem—Dysgeusia—Epirubicin—hematologic cancer	5.57e-05	5.57e-05	CcSEcCtD
Ertapenem—Hypersensitivity—Triamcinolone—hematologic cancer	5.53e-05	5.53e-05	CcSEcCtD
Ertapenem—Nervousness—Epirubicin—hematologic cancer	5.53e-05	5.53e-05	CcSEcCtD
Ertapenem—Angiopathy—Doxorubicin—hematologic cancer	5.49e-05	5.49e-05	CcSEcCtD
Ertapenem—Malaise—Methotrexate—hematologic cancer	5.48e-05	5.48e-05	CcSEcCtD
Ertapenem—Dizziness—Etoposide—hematologic cancer	5.48e-05	5.48e-05	CcSEcCtD
Ertapenem—Muscle spasms—Epirubicin—hematologic cancer	5.47e-05	5.47e-05	CcSEcCtD
Ertapenem—Immune system disorder—Doxorubicin—hematologic cancer	5.46e-05	5.46e-05	CcSEcCtD
Ertapenem—Vertigo—Methotrexate—hematologic cancer	5.46e-05	5.46e-05	CcSEcCtD
Ertapenem—Mediastinal disorder—Doxorubicin—hematologic cancer	5.45e-05	5.45e-05	CcSEcCtD
Ertapenem—Chills—Doxorubicin—hematologic cancer	5.43e-05	5.43e-05	CcSEcCtD
Ertapenem—Urticaria—Dexamethasone—hematologic cancer	5.42e-05	5.42e-05	CcSEcCtD
Ertapenem—Urticaria—Betamethasone—hematologic cancer	5.42e-05	5.42e-05	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Prednisone—hematologic cancer	5.41e-05	5.41e-05	CcSEcCtD
Ertapenem—Dizziness—Prednisolone—hematologic cancer	5.4e-05	5.4e-05	CcSEcCtD
Ertapenem—Arrhythmia—Doxorubicin—hematologic cancer	5.4e-05	5.4e-05	CcSEcCtD
Ertapenem—Asthenia—Triamcinolone—hematologic cancer	5.39e-05	5.39e-05	CcSEcCtD
Ertapenem—Abdominal pain—Betamethasone—hematologic cancer	5.39e-05	5.39e-05	CcSEcCtD
Ertapenem—Abdominal pain—Dexamethasone—hematologic cancer	5.39e-05	5.39e-05	CcSEcCtD
Ertapenem—Body temperature increased—Betamethasone—hematologic cancer	5.39e-05	5.39e-05	CcSEcCtD
Ertapenem—Body temperature increased—Dexamethasone—hematologic cancer	5.39e-05	5.39e-05	CcSEcCtD
Ertapenem—Nausea—Cisplatin—hematologic cancer	5.37e-05	5.37e-05	CcSEcCtD
Ertapenem—Insomnia—Prednisone—hematologic cancer	5.37e-05	5.37e-05	CcSEcCtD
Ertapenem—Paraesthesia—Prednisone—hematologic cancer	5.33e-05	5.33e-05	CcSEcCtD
Ertapenem—Pruritus—Triamcinolone—hematologic cancer	5.32e-05	5.32e-05	CcSEcCtD
Ertapenem—Cough—Methotrexate—hematologic cancer	5.3e-05	5.3e-05	CcSEcCtD
Ertapenem—Mental disorder—Doxorubicin—hematologic cancer	5.3e-05	5.3e-05	CcSEcCtD
Ertapenem—Ill-defined disorder—Epirubicin—hematologic cancer	5.28e-05	5.28e-05	CcSEcCtD
Ertapenem—Convulsion—Methotrexate—hematologic cancer	5.27e-05	5.27e-05	CcSEcCtD
Ertapenem—Vomiting—Etoposide—hematologic cancer	5.27e-05	5.27e-05	CcSEcCtD
Ertapenem—Malnutrition—Doxorubicin—hematologic cancer	5.26e-05	5.26e-05	CcSEcCtD
Ertapenem—Erythema—Doxorubicin—hematologic cancer	5.26e-05	5.26e-05	CcSEcCtD
Ertapenem—Anaemia—Epirubicin—hematologic cancer	5.26e-05	5.26e-05	CcSEcCtD
Ertapenem—Agitation—Epirubicin—hematologic cancer	5.23e-05	5.23e-05	CcSEcCtD
Ertapenem—Dyspepsia—Prednisone—hematologic cancer	5.23e-05	5.23e-05	CcSEcCtD
Ertapenem—Rash—Etoposide—hematologic cancer	5.22e-05	5.22e-05	CcSEcCtD
Ertapenem—Dermatitis—Etoposide—hematologic cancer	5.22e-05	5.22e-05	CcSEcCtD
Ertapenem—Headache—Etoposide—hematologic cancer	5.19e-05	5.19e-05	CcSEcCtD
Ertapenem—Flatulence—Doxorubicin—hematologic cancer	5.19e-05	5.19e-05	CcSEcCtD
Ertapenem—Arthralgia—Methotrexate—hematologic cancer	5.18e-05	5.18e-05	CcSEcCtD
Ertapenem—Chest pain—Methotrexate—hematologic cancer	5.18e-05	5.18e-05	CcSEcCtD
Ertapenem—Tension—Doxorubicin—hematologic cancer	5.17e-05	5.17e-05	CcSEcCtD
Ertapenem—Decreased appetite—Prednisone—hematologic cancer	5.16e-05	5.16e-05	CcSEcCtD
Ertapenem—Dysgeusia—Doxorubicin—hematologic cancer	5.15e-05	5.15e-05	CcSEcCtD
Ertapenem—Rash—Prednisolone—hematologic cancer	5.15e-05	5.15e-05	CcSEcCtD
Ertapenem—Dermatitis—Prednisolone—hematologic cancer	5.15e-05	5.15e-05	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	5.14e-05	5.14e-05	CcSEcCtD
Ertapenem—Malaise—Epirubicin—hematologic cancer	5.13e-05	5.13e-05	CcSEcCtD
Ertapenem—Fatigue—Prednisone—hematologic cancer	5.12e-05	5.12e-05	CcSEcCtD
Ertapenem—Headache—Prednisolone—hematologic cancer	5.12e-05	5.12e-05	CcSEcCtD
Ertapenem—Discomfort—Methotrexate—hematologic cancer	5.11e-05	5.11e-05	CcSEcCtD
Ertapenem—Nervousness—Doxorubicin—hematologic cancer	5.11e-05	5.11e-05	CcSEcCtD
Ertapenem—Vertigo—Epirubicin—hematologic cancer	5.11e-05	5.11e-05	CcSEcCtD
Ertapenem—Syncope—Epirubicin—hematologic cancer	5.1e-05	5.1e-05	CcSEcCtD
Ertapenem—Constipation—Prednisone—hematologic cancer	5.08e-05	5.08e-05	CcSEcCtD
Ertapenem—Muscle spasms—Doxorubicin—hematologic cancer	5.06e-05	5.06e-05	CcSEcCtD
Ertapenem—Confusional state—Methotrexate—hematologic cancer	5e-05	5e-05	CcSEcCtD
Ertapenem—Loss of consciousness—Epirubicin—hematologic cancer	5e-05	5e-05	CcSEcCtD
Ertapenem—Dizziness—Triamcinolone—hematologic cancer	4.97e-05	4.97e-05	CcSEcCtD
Ertapenem—Cough—Epirubicin—hematologic cancer	4.96e-05	4.96e-05	CcSEcCtD
Ertapenem—Anaphylactic shock—Methotrexate—hematologic cancer	4.96e-05	4.96e-05	CcSEcCtD
Ertapenem—Convulsion—Epirubicin—hematologic cancer	4.93e-05	4.93e-05	CcSEcCtD
Ertapenem—Infection—Methotrexate—hematologic cancer	4.93e-05	4.93e-05	CcSEcCtD
Ertapenem—Nausea—Etoposide—hematologic cancer	4.92e-05	4.92e-05	CcSEcCtD
Ertapenem—Hypertension—Epirubicin—hematologic cancer	4.91e-05	4.91e-05	CcSEcCtD
Ertapenem—Feeling abnormal—Prednisone—hematologic cancer	4.89e-05	4.89e-05	CcSEcCtD
Ertapenem—Asthenia—Dexamethasone—hematologic cancer	4.89e-05	4.89e-05	CcSEcCtD
Ertapenem—Asthenia—Betamethasone—hematologic cancer	4.89e-05	4.89e-05	CcSEcCtD
Ertapenem—Ill-defined disorder—Doxorubicin—hematologic cancer	4.88e-05	4.88e-05	CcSEcCtD
Ertapenem—Nervous system disorder—Methotrexate—hematologic cancer	4.87e-05	4.87e-05	CcSEcCtD
Ertapenem—Anaemia—Doxorubicin—hematologic cancer	4.87e-05	4.87e-05	CcSEcCtD
Ertapenem—Thrombocytopenia—Methotrexate—hematologic cancer	4.86e-05	4.86e-05	CcSEcCtD
Ertapenem—Gastrointestinal pain—Prednisone—hematologic cancer	4.85e-05	4.85e-05	CcSEcCtD
Ertapenem—Nausea—Prednisolone—hematologic cancer	4.85e-05	4.85e-05	CcSEcCtD
Ertapenem—Chest pain—Epirubicin—hematologic cancer	4.84e-05	4.84e-05	CcSEcCtD
Ertapenem—Arthralgia—Epirubicin—hematologic cancer	4.84e-05	4.84e-05	CcSEcCtD
Ertapenem—Agitation—Doxorubicin—hematologic cancer	4.84e-05	4.84e-05	CcSEcCtD
Ertapenem—Anxiety—Epirubicin—hematologic cancer	4.83e-05	4.83e-05	CcSEcCtD
Ertapenem—Pruritus—Dexamethasone—hematologic cancer	4.82e-05	4.82e-05	CcSEcCtD
Ertapenem—Pruritus—Betamethasone—hematologic cancer	4.82e-05	4.82e-05	CcSEcCtD
Ertapenem—Skin disorder—Methotrexate—hematologic cancer	4.82e-05	4.82e-05	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.81e-05	4.81e-05	CcSEcCtD
Ertapenem—Hyperhidrosis—Methotrexate—hematologic cancer	4.8e-05	4.8e-05	CcSEcCtD
Ertapenem—Discomfort—Epirubicin—hematologic cancer	4.79e-05	4.79e-05	CcSEcCtD
Ertapenem—Vomiting—Triamcinolone—hematologic cancer	4.78e-05	4.78e-05	CcSEcCtD
Ertapenem—Malaise—Doxorubicin—hematologic cancer	4.75e-05	4.75e-05	CcSEcCtD
Ertapenem—Rash—Triamcinolone—hematologic cancer	4.74e-05	4.74e-05	CcSEcCtD
Ertapenem—Dry mouth—Epirubicin—hematologic cancer	4.74e-05	4.74e-05	CcSEcCtD
Ertapenem—Dermatitis—Triamcinolone—hematologic cancer	4.73e-05	4.73e-05	CcSEcCtD
Ertapenem—Vertigo—Doxorubicin—hematologic cancer	4.73e-05	4.73e-05	CcSEcCtD
Ertapenem—Anorexia—Methotrexate—hematologic cancer	4.73e-05	4.73e-05	CcSEcCtD
Ertapenem—Syncope—Doxorubicin—hematologic cancer	4.72e-05	4.72e-05	CcSEcCtD
Ertapenem—Urticaria—Prednisone—hematologic cancer	4.72e-05	4.72e-05	CcSEcCtD
Ertapenem—Headache—Triamcinolone—hematologic cancer	4.71e-05	4.71e-05	CcSEcCtD
Ertapenem—Body temperature increased—Prednisone—hematologic cancer	4.69e-05	4.69e-05	CcSEcCtD
Ertapenem—Abdominal pain—Prednisone—hematologic cancer	4.69e-05	4.69e-05	CcSEcCtD
Ertapenem—Confusional state—Epirubicin—hematologic cancer	4.68e-05	4.68e-05	CcSEcCtD
Ertapenem—Diarrhoea—Betamethasone—hematologic cancer	4.66e-05	4.66e-05	CcSEcCtD
Ertapenem—Diarrhoea—Dexamethasone—hematologic cancer	4.66e-05	4.66e-05	CcSEcCtD
Ertapenem—Anaphylactic shock—Epirubicin—hematologic cancer	4.64e-05	4.64e-05	CcSEcCtD
Ertapenem—Oedema—Epirubicin—hematologic cancer	4.64e-05	4.64e-05	CcSEcCtD
Ertapenem—Hypotension—Methotrexate—hematologic cancer	4.64e-05	4.64e-05	CcSEcCtD
Ertapenem—Loss of consciousness—Doxorubicin—hematologic cancer	4.63e-05	4.63e-05	CcSEcCtD
Ertapenem—Infection—Epirubicin—hematologic cancer	4.61e-05	4.61e-05	CcSEcCtD
Ertapenem—Cough—Doxorubicin—hematologic cancer	4.59e-05	4.59e-05	CcSEcCtD
Ertapenem—Shock—Epirubicin—hematologic cancer	4.57e-05	4.57e-05	CcSEcCtD
Ertapenem—Convulsion—Doxorubicin—hematologic cancer	4.56e-05	4.56e-05	CcSEcCtD
Ertapenem—Nervous system disorder—Epirubicin—hematologic cancer	4.55e-05	4.55e-05	CcSEcCtD
Ertapenem—Thrombocytopenia—Epirubicin—hematologic cancer	4.55e-05	4.55e-05	CcSEcCtD
Ertapenem—Hypertension—Doxorubicin—hematologic cancer	4.54e-05	4.54e-05	CcSEcCtD
Ertapenem—Tachycardia—Epirubicin—hematologic cancer	4.53e-05	4.53e-05	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.52e-05	4.52e-05	CcSEcCtD
Ertapenem—Skin disorder—Epirubicin—hematologic cancer	4.51e-05	4.51e-05	CcSEcCtD
Ertapenem—Dizziness—Dexamethasone—hematologic cancer	4.51e-05	4.51e-05	CcSEcCtD
Ertapenem—Dizziness—Betamethasone—hematologic cancer	4.51e-05	4.51e-05	CcSEcCtD
Ertapenem—Hyperhidrosis—Epirubicin—hematologic cancer	4.49e-05	4.49e-05	CcSEcCtD
Ertapenem—Insomnia—Methotrexate—hematologic cancer	4.49e-05	4.49e-05	CcSEcCtD
Ertapenem—Arthralgia—Doxorubicin—hematologic cancer	4.48e-05	4.48e-05	CcSEcCtD
Ertapenem—Chest pain—Doxorubicin—hematologic cancer	4.48e-05	4.48e-05	CcSEcCtD
Ertapenem—Anxiety—Doxorubicin—hematologic cancer	4.47e-05	4.47e-05	CcSEcCtD
Ertapenem—Nausea—Triamcinolone—hematologic cancer	4.46e-05	4.46e-05	CcSEcCtD
Ertapenem—Paraesthesia—Methotrexate—hematologic cancer	4.45e-05	4.45e-05	CcSEcCtD
Ertapenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.45e-05	4.45e-05	CcSEcCtD
Ertapenem—Discomfort—Doxorubicin—hematologic cancer	4.43e-05	4.43e-05	CcSEcCtD
Ertapenem—Anorexia—Epirubicin—hematologic cancer	4.43e-05	4.43e-05	CcSEcCtD
Ertapenem—Dyspnoea—Methotrexate—hematologic cancer	4.42e-05	4.42e-05	CcSEcCtD
Ertapenem—Somnolence—Methotrexate—hematologic cancer	4.41e-05	4.41e-05	CcSEcCtD
Ertapenem—Dry mouth—Doxorubicin—hematologic cancer	4.38e-05	4.38e-05	CcSEcCtD
Ertapenem—Hypersensitivity—Prednisone—hematologic cancer	4.37e-05	4.37e-05	CcSEcCtD
Ertapenem—Dyspepsia—Methotrexate—hematologic cancer	4.37e-05	4.37e-05	CcSEcCtD
Ertapenem—Hypotension—Epirubicin—hematologic cancer	4.34e-05	4.34e-05	CcSEcCtD
Ertapenem—Vomiting—Betamethasone—hematologic cancer	4.33e-05	4.33e-05	CcSEcCtD
Ertapenem—Vomiting—Dexamethasone—hematologic cancer	4.33e-05	4.33e-05	CcSEcCtD
Ertapenem—Confusional state—Doxorubicin—hematologic cancer	4.33e-05	4.33e-05	CcSEcCtD
Ertapenem—Decreased appetite—Methotrexate—hematologic cancer	4.31e-05	4.31e-05	CcSEcCtD
Ertapenem—Rash—Dexamethasone—hematologic cancer	4.3e-05	4.3e-05	CcSEcCtD
Ertapenem—Rash—Betamethasone—hematologic cancer	4.3e-05	4.3e-05	CcSEcCtD
Ertapenem—Oedema—Doxorubicin—hematologic cancer	4.3e-05	4.3e-05	CcSEcCtD
Ertapenem—Anaphylactic shock—Doxorubicin—hematologic cancer	4.3e-05	4.3e-05	CcSEcCtD
Ertapenem—Dermatitis—Betamethasone—hematologic cancer	4.29e-05	4.29e-05	CcSEcCtD
Ertapenem—Dermatitis—Dexamethasone—hematologic cancer	4.29e-05	4.29e-05	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Methotrexate—hematologic cancer	4.28e-05	4.28e-05	CcSEcCtD
Ertapenem—Fatigue—Methotrexate—hematologic cancer	4.28e-05	4.28e-05	CcSEcCtD
Ertapenem—Headache—Dexamethasone—hematologic cancer	4.27e-05	4.27e-05	CcSEcCtD
Ertapenem—Headache—Betamethasone—hematologic cancer	4.27e-05	4.27e-05	CcSEcCtD
Ertapenem—Infection—Doxorubicin—hematologic cancer	4.27e-05	4.27e-05	CcSEcCtD
Ertapenem—Asthenia—Prednisone—hematologic cancer	4.26e-05	4.26e-05	CcSEcCtD
Ertapenem—Pain—Methotrexate—hematologic cancer	4.24e-05	4.24e-05	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.23e-05	4.23e-05	CcSEcCtD
Ertapenem—Shock—Doxorubicin—hematologic cancer	4.23e-05	4.23e-05	CcSEcCtD
Ertapenem—Nervous system disorder—Doxorubicin—hematologic cancer	4.21e-05	4.21e-05	CcSEcCtD
Ertapenem—Thrombocytopenia—Doxorubicin—hematologic cancer	4.21e-05	4.21e-05	CcSEcCtD
Ertapenem—Pruritus—Prednisone—hematologic cancer	4.2e-05	4.2e-05	CcSEcCtD
Ertapenem—Insomnia—Epirubicin—hematologic cancer	4.2e-05	4.2e-05	CcSEcCtD
Ertapenem—Tachycardia—Doxorubicin—hematologic cancer	4.19e-05	4.19e-05	CcSEcCtD
Ertapenem—Skin disorder—Doxorubicin—hematologic cancer	4.17e-05	4.17e-05	CcSEcCtD
Ertapenem—Paraesthesia—Epirubicin—hematologic cancer	4.17e-05	4.17e-05	CcSEcCtD
Ertapenem—Hyperhidrosis—Doxorubicin—hematologic cancer	4.15e-05	4.15e-05	CcSEcCtD
Ertapenem—Dyspnoea—Epirubicin—hematologic cancer	4.14e-05	4.14e-05	CcSEcCtD
Ertapenem—Somnolence—Epirubicin—hematologic cancer	4.13e-05	4.13e-05	CcSEcCtD
Ertapenem—Anorexia—Doxorubicin—hematologic cancer	4.09e-05	4.09e-05	CcSEcCtD
Ertapenem—Feeling abnormal—Methotrexate—hematologic cancer	4.09e-05	4.09e-05	CcSEcCtD
Ertapenem—Dyspepsia—Epirubicin—hematologic cancer	4.09e-05	4.09e-05	CcSEcCtD
Ertapenem—Diarrhoea—Prednisone—hematologic cancer	4.06e-05	4.06e-05	CcSEcCtD
Ertapenem—Gastrointestinal pain—Methotrexate—hematologic cancer	4.06e-05	4.06e-05	CcSEcCtD
Ertapenem—Nausea—Betamethasone—hematologic cancer	4.05e-05	4.05e-05	CcSEcCtD
Ertapenem—Nausea—Dexamethasone—hematologic cancer	4.05e-05	4.05e-05	CcSEcCtD
Ertapenem—Decreased appetite—Epirubicin—hematologic cancer	4.04e-05	4.04e-05	CcSEcCtD
Ertapenem—Hypotension—Doxorubicin—hematologic cancer	4.01e-05	4.01e-05	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Epirubicin—hematologic cancer	4.01e-05	4.01e-05	CcSEcCtD
Ertapenem—Fatigue—Epirubicin—hematologic cancer	4e-05	4e-05	CcSEcCtD
Ertapenem—Pain—Epirubicin—hematologic cancer	3.97e-05	3.97e-05	CcSEcCtD
Ertapenem—Constipation—Epirubicin—hematologic cancer	3.97e-05	3.97e-05	CcSEcCtD
Ertapenem—Urticaria—Methotrexate—hematologic cancer	3.94e-05	3.94e-05	CcSEcCtD
Ertapenem—Dizziness—Prednisone—hematologic cancer	3.93e-05	3.93e-05	CcSEcCtD
Ertapenem—Body temperature increased—Methotrexate—hematologic cancer	3.92e-05	3.92e-05	CcSEcCtD
Ertapenem—Abdominal pain—Methotrexate—hematologic cancer	3.92e-05	3.92e-05	CcSEcCtD
Ertapenem—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.91e-05	3.91e-05	CcSEcCtD
Ertapenem—Insomnia—Doxorubicin—hematologic cancer	3.89e-05	3.89e-05	CcSEcCtD
Ertapenem—Paraesthesia—Doxorubicin—hematologic cancer	3.86e-05	3.86e-05	CcSEcCtD
Ertapenem—Dyspnoea—Doxorubicin—hematologic cancer	3.83e-05	3.83e-05	CcSEcCtD
Ertapenem—Feeling abnormal—Epirubicin—hematologic cancer	3.83e-05	3.83e-05	CcSEcCtD
Ertapenem—Somnolence—Doxorubicin—hematologic cancer	3.82e-05	3.82e-05	CcSEcCtD
Ertapenem—Gastrointestinal pain—Epirubicin—hematologic cancer	3.8e-05	3.8e-05	CcSEcCtD
Ertapenem—Dyspepsia—Doxorubicin—hematologic cancer	3.78e-05	3.78e-05	CcSEcCtD
Ertapenem—Vomiting—Prednisone—hematologic cancer	3.77e-05	3.77e-05	CcSEcCtD
Ertapenem—Rash—Prednisone—hematologic cancer	3.74e-05	3.74e-05	CcSEcCtD
Ertapenem—Dermatitis—Prednisone—hematologic cancer	3.74e-05	3.74e-05	CcSEcCtD
Ertapenem—Decreased appetite—Doxorubicin—hematologic cancer	3.73e-05	3.73e-05	CcSEcCtD
Ertapenem—Headache—Prednisone—hematologic cancer	3.72e-05	3.72e-05	CcSEcCtD
Ertapenem—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.71e-05	3.71e-05	CcSEcCtD
Ertapenem—Fatigue—Doxorubicin—hematologic cancer	3.7e-05	3.7e-05	CcSEcCtD
Ertapenem—Urticaria—Epirubicin—hematologic cancer	3.69e-05	3.69e-05	CcSEcCtD
Ertapenem—Pain—Doxorubicin—hematologic cancer	3.67e-05	3.67e-05	CcSEcCtD
Ertapenem—Constipation—Doxorubicin—hematologic cancer	3.67e-05	3.67e-05	CcSEcCtD
Ertapenem—Abdominal pain—Epirubicin—hematologic cancer	3.67e-05	3.67e-05	CcSEcCtD
Ertapenem—Body temperature increased—Epirubicin—hematologic cancer	3.67e-05	3.67e-05	CcSEcCtD
Ertapenem—Hypersensitivity—Methotrexate—hematologic cancer	3.66e-05	3.66e-05	CcSEcCtD
Ertapenem—Asthenia—Methotrexate—hematologic cancer	3.56e-05	3.56e-05	CcSEcCtD
Ertapenem—Feeling abnormal—Doxorubicin—hematologic cancer	3.54e-05	3.54e-05	CcSEcCtD
Ertapenem—Nausea—Prednisone—hematologic cancer	3.53e-05	3.53e-05	CcSEcCtD
Ertapenem—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.51e-05	3.51e-05	CcSEcCtD
Ertapenem—Pruritus—Methotrexate—hematologic cancer	3.51e-05	3.51e-05	CcSEcCtD
Ertapenem—Hypersensitivity—Epirubicin—hematologic cancer	3.42e-05	3.42e-05	CcSEcCtD
Ertapenem—Urticaria—Doxorubicin—hematologic cancer	3.41e-05	3.41e-05	CcSEcCtD
Ertapenem—Body temperature increased—Doxorubicin—hematologic cancer	3.4e-05	3.4e-05	CcSEcCtD
Ertapenem—Abdominal pain—Doxorubicin—hematologic cancer	3.4e-05	3.4e-05	CcSEcCtD
Ertapenem—Diarrhoea—Methotrexate—hematologic cancer	3.39e-05	3.39e-05	CcSEcCtD
Ertapenem—Asthenia—Epirubicin—hematologic cancer	3.33e-05	3.33e-05	CcSEcCtD
Ertapenem—Pruritus—Epirubicin—hematologic cancer	3.28e-05	3.28e-05	CcSEcCtD
Ertapenem—Dizziness—Methotrexate—hematologic cancer	3.28e-05	3.28e-05	CcSEcCtD
Ertapenem—Diarrhoea—Epirubicin—hematologic cancer	3.18e-05	3.18e-05	CcSEcCtD
Ertapenem—Hypersensitivity—Doxorubicin—hematologic cancer	3.17e-05	3.17e-05	CcSEcCtD
Ertapenem—Vomiting—Methotrexate—hematologic cancer	3.15e-05	3.15e-05	CcSEcCtD
Ertapenem—Rash—Methotrexate—hematologic cancer	3.13e-05	3.13e-05	CcSEcCtD
Ertapenem—Dermatitis—Methotrexate—hematologic cancer	3.13e-05	3.13e-05	CcSEcCtD
Ertapenem—Headache—Methotrexate—hematologic cancer	3.11e-05	3.11e-05	CcSEcCtD
Ertapenem—Asthenia—Doxorubicin—hematologic cancer	3.08e-05	3.08e-05	CcSEcCtD
Ertapenem—Dizziness—Epirubicin—hematologic cancer	3.07e-05	3.07e-05	CcSEcCtD
Ertapenem—Pruritus—Doxorubicin—hematologic cancer	3.04e-05	3.04e-05	CcSEcCtD
Ertapenem—Vomiting—Epirubicin—hematologic cancer	2.95e-05	2.95e-05	CcSEcCtD
Ertapenem—Nausea—Methotrexate—hematologic cancer	2.95e-05	2.95e-05	CcSEcCtD
Ertapenem—Diarrhoea—Doxorubicin—hematologic cancer	2.94e-05	2.94e-05	CcSEcCtD
Ertapenem—Rash—Epirubicin—hematologic cancer	2.93e-05	2.93e-05	CcSEcCtD
Ertapenem—Dermatitis—Epirubicin—hematologic cancer	2.92e-05	2.92e-05	CcSEcCtD
Ertapenem—Headache—Epirubicin—hematologic cancer	2.91e-05	2.91e-05	CcSEcCtD
Ertapenem—Dizziness—Doxorubicin—hematologic cancer	2.84e-05	2.84e-05	CcSEcCtD
Ertapenem—Nausea—Epirubicin—hematologic cancer	2.76e-05	2.76e-05	CcSEcCtD
Ertapenem—Vomiting—Doxorubicin—hematologic cancer	2.73e-05	2.73e-05	CcSEcCtD
Ertapenem—Rash—Doxorubicin—hematologic cancer	2.71e-05	2.71e-05	CcSEcCtD
Ertapenem—Dermatitis—Doxorubicin—hematologic cancer	2.71e-05	2.71e-05	CcSEcCtD
Ertapenem—Headache—Doxorubicin—hematologic cancer	2.69e-05	2.69e-05	CcSEcCtD
Ertapenem—Nausea—Doxorubicin—hematologic cancer	2.55e-05	2.55e-05	CcSEcCtD
